Inhalable liposomal delivery of osimertinib and DNA for treating primary and metastasis lung cancer

Abstract excerpt

Lung cancer remains one of the most common malignancies, and its brain metastases significantly worsen the prognosis for patients. Current treatments for lung cancer face many challenges, including poor drug accumulation and the inability to simultaneously control primary and metastatic tumors. Here, we show that the mRNA-binding protein insulin-like growth factor 3 is crucial for non-small cell lung cancer...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Extracellular vesicles in disease
• Share to Inhalation and Respiratory Drug Delivery
• Share to MicroRNA in disease regulation